Navigation Links
AstraZeneca Launches New Program to Support Facilities that Connect People to Needed Medical Care and Prescription Assistance
Date:10/1/2007

AZ&Me(TM) Prescription Savings program for healthcare facilities helps

uninsured patients access medicine at little to no cost

WILMINGTON, Del., Oct. 1 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) launched a new program today to provide medicines free of charge to community free clinics, community health centers and hospitals that serve the uninsured. The AZ&Me(TM) Prescription Savings program for healthcare facilities is planning to provide free AstraZeneca medicines to hundreds of thousands of patients at approximately 150 facilities by the end of 2008.

The new program builds on the current AstraZeneca patient assistance programs by extending prescription drug assistance directly to the sites where uninsured patients interact with healthcare providers, supporting patients at one central place where they can get the medicine and care they need.

"AstraZeneca knows it is not enough to make lifesaving medicines. We must also ensure people have access to our products," said David Nicoli, Vice President of Corporate Affairs. "This program supports facilities that connect patients to medical care such as disease management, preventive care and dental care. AstraZeneca believes that through programs like this we can help people get the care and medicine they need."

The AZ&Me(TM) Prescription Savings program for healthcare facilities is available to organizations that have a licensed outpatient pharmacy or dispensary on site and can provide documentation that their facility meets other program criteria. Patients are eligible for AstraZeneca medicines through this program if they do not have prescription drug coverage and must have a household income at or below $30,000 for an individual, or $60,000 for a family of four.

"The AZ&Me(TM) Prescription Savings program for healthcare facilities is targeting a population that really needs support. One of the common problems with uninsured patients is that, not only do they not receive the medicine they need, they are not under the regular care of a physician or other healthcare professional. This program supports organizations like free clinics that serve these patients," said Nicole Lamoreaux, Executive Director, National Association of Free Clinics. "AstraZeneca reached out to our Board for input on the new program design as a way to ensure that facilities would understand how to use it, be able to comply with the requirements and, ultimately, to ensure that the enhancements would enable health care facilities to help patients."

With this new program, AstraZeneca expands on its nearly 30-year history of helping patients afford the medicines they need. Last year, for example, AstraZeneca expanded eligibility for the AZ&Me(TM) Prescription Savings program for people without insurance to $60,000 for a family of four, or $30,000 for an individual, and also launched the first retail-based assistance program for people with Medicare Part D.

In light of the updates to the AstraZeneca patient assistance programs in the last year, AstraZeneca has decided to no longer participate in the Together Rx Access program after January 31, 2008. Instead, the company will focus on providing assistance to patients, including those currently getting AstraZeneca medicines through Together Rx Access, through its expanded assistance program. AstraZeneca programs provide medicines free of charge to those making up to $30,000 for an individual, or $60,000 for a family of four. AstraZeneca continues to encourage patients to use the Together Rx Access Card to receive savings on their medications from other companies. AstraZeneca also supports a variety of programs such as Partnership for Prescription Assistance that connects patients to programs that could help.

"Patients are saving millions of dollars through the Together Rx Access program," Nicoli said. "We are proud to have provided support for patients through that program, and we encourage patients to continue to use Together Rx Access to receive savings on non-AstraZeneca medicines."

To learn if your organization could qualify for the AZ&Me(TM) Prescription Savings program for healthcare facilities, please call 1-866-325-8198. Program specialists are available Monday through Friday between the hours of 9:00 AM and 5:00 PM EDT.

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.

In the United States, AstraZeneca is a $12.44 billion healthcare business with more than 12,000 employees. For nearly three decades, AstraZeneca has offered drug assistance programs side by side with its medicines, and over the past five years, has provided over $3 billion in savings to more than 1 million patients throughout the U.S. and Puerto Rico. AstraZeneca has been named one of the "100 Best Companies for Working Mothers" by Working Mother magazine and is the only large pharmaceutical company named to FORTUNE magazine's 2007 list of "100 Best Companies to Work For." In 2006, for the fifth consecutive year, Science magazine named AstraZeneca a "Top Employer" on its ranking of the world's most respected biopharmaceutical employers.

For more information about AstraZeneca, please visit: http://www.astrazeneca-us.com


'/>"/>
SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Astrazenecas Investigational Cancer Therapies Revealed at ASCO
2. Glaxo launches pills to help smokers quit in 7-12 weeks
3. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
4. Dr Reddy’s Laboratories launches Hyalosy
5. Serum Institute Launches New Tetanus-Diphtheria Vaccine
6. Scottish Health Minister Launches Organ Donor Plan
7. GlaxoSmithKline launches diabetes and cancer drugs
8. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
9. Pfizer Launches Viagra For Lung Disease In UK
10. PM Launches Healthcare Foundation For India
11. African Union Launches A Programme On Acceleration of HIV Prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... The old expression “a ... problem. A common injury that’s often misunderstood, whiplash should be swiftly diagnosed and treated ... orthopedic spine surgeon at Atlantic Spine Center . , So named because ...
(Date:5/24/2016)... ... 24, 2016 , ... Researchers from Catholic Health Initiatives (CHI) ... bleeding complications from percutaneous coronary intervention (PCI). The data, presented at the annual ... document a 40% reduction in risk-adjusted bleeding event rates over a two-year period ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... web-based software module. The cutting-edge feature provides end users with an embedded, ... self-service business intelligence solution and its analytics engine. , This powerful ...
(Date:5/23/2016)... Akron, Ohio (PRWEB) , ... May 23, 2016 ... ... not-for-profit continuing care retirement community, dedicated its new $11.5 million, 64-room assisted living ... an invitation-only ceremony and ribbon cutting. , The new building provides the ...
(Date:5/23/2016)... ... May 23, 2016 , ... According to an article ... than 1% of United Kingdom residents who could benefit from bariatric surgery are actually ... increases the number of bariatric procedures it offers to obese patients from 6,000 to ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... 19, 2016 A new report ... Market -Opportunities and Forecasts, 2015 -2022, projects that the ... 2022, registering a CAGR of 5.1% from 2015 to ... be the highest revenue-generating segment throughout the forecast period. ... one-third of the market share in 2015, and is ...
(Date:5/19/2016)... -- The equities market is never short of ... is without doubt the Healthcare space. ActiveWallSt.com has uncovered four ... Alkermes PLC (NASDAQ: ALKS ), AMAG Pharmaceuticals Inc. ... IDXX ), and Atossa Genetics Inc. (NASDAQ: ... http://www.activewallst.com/ On Wednesday, Alkermes PLC,s ...
(Date:5/19/2016)... 19, 2016 MGB Biopharma, ... of Anti-infectives, Welcomes the Final Instalment of Lord ... Today   Lord Jim O,Neill,s ... final recommendations, providing a comprehensive action plan for ... the rising threat of superbugs - something that ...
Breaking Medicine Technology: